FDA Warning Letter — JMA Partners
The FDA took a Warning Letter action against JMA Partners on Nov 3, 2017 (Dallas, TX). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- JMA Partners
- Date
- Nov 3, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Center
- CDER
- Location
- Dallas, TX (United States)